Common Sense Oncology shared a post on LinkedIn:
“CSO was at ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond.”
You Can Also Read:
ESMO 2025 Day 1 Highlights Not to Miss
POTOMAC Trial at ESMO 2025: Durvalumab Plus BCG Improves Outcomes in High-Risk NMIBC
ESMO Announces the 2025 Society Award Winners
